158CMX PANTONE(R) 158 C SIMULATION 4675CGNSPL PANTONE(R) 4675 C SIMULATION

313CGNS PANTONE(R) 313 C SIMULATION 3145CGNS PANTONE(R) 3145 C SIMULATION

427CGNSPL PANTONE(R) 427 C SIMULATION 429CGNSPL PANTONE(R) 429 C SIMULATION

R-116M RED IRON OXIDE PRIMARIES R-481 RED IRON OXIDE PRIMARIES

A focus on R&D  With our R&D focus on innovative chemistry to tackle and overcome the plastics recycling challenge Avient has officially opened our new CycleWorks facility in northern Italy.  

Polystrand™ R Recycled Polyester Composite Tape and Laminates - Product Bulletin Learn more about key characteristics, applications and technical properties for Polystrand R Recycled Polyester Composite Tape and Laminates

These and other projects benefit the planet by minimizing the amount of natural resources required to safely manufacture, transport and ensure first-time quality material to our customers. Kunkle, Senior Vice President, General Counsel and Secretary(1) Joel R. Shares Available Under this Plan (a) (i) Section 12 Section 3(b) ( ) Section 9 Section 10 2017 Plan (ii) Section 3(b)( ) Section 3(a)(i) ( )( ) (b) (i) Section 22 Section 3(a)(i) ( )( ) (ii) (iii) Section 3(a)(i) ( )( ) Section 3(a)(i) ( )( ) Section 3(a)(i)( )( ) Section 3(a)(i)( )( ) (iv) Section 3(a)(i)( )( ) (c) Section 3 Section 12 (d) Section 3 (e) Section 3(e)( ) Section 3(a)(i) Section 12( )( ) Section 3(e)( ) Section 17(c)( ) 4.

Microsoft PowerPoint - AVNT M11 Investor Presentation AVIENT CORPORATION I N V E S T O R P R E S E N T A T I O N (NYSE: AVNT) N OV E M B E R 2 0 2 4 DISCLAIMER Forward-Looking Statements Certain statements contained in or incorporated by reference into this presentation constitute “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. EBITDA $130 million +6% (+7% ex FX)Net Sales $815 million +8% (+8.5% ex FX) Net Sales $815 million +8% (+8.5% ex FX) Q 3 2024 R ES U LT S TOTAL COMPANY (Q3 2024 PERFORMANCE VS Q3 2023) $754 $815 Q3 23 Q3 24 $123 $130 Q3 23 Q3 24 Sales Adjusted EBITDA (in millions) $0.57 $0.65 Q3 23 Q3 24 (in millions) Adjusted EBITDA Adjusted EPS 8 + 8% (+8.5% excluding FX) + 6% (+7% excluding FX) + 14% (+16% excluding FX) Sales 9 Q3 2024 RESULTS – ORGANIC REVENUE GROWTH BY REGION VS PY 9 US & Canada Latin America EMEA Asia +9% +5% +11% +27% Avient ex. Senior management believes the measures described above are useful to investors because they allow for comparison to Avient's performance in prior periods without the effect of items that, by their nature, tend to obscure Avient's operating results due to the potential variability across periods based on timing, frequency and magnitude.

A LIFE SCIENCE COMPANY S E R U M C O L L E C T I O N C A R T R I D G E • Excellent clarity • Good bonding and peel strength onto PP • Heat resistance • Meet sterilization needs • Easy processing • Formulated transparent Shore 50A TPE with excellent adhesion onto PP and good sealing performance • Met regulatory requirements for USP Class VI and ISO 10993-4,5 • Provided a short lead time and on-site technical service Versaflex™ CL Thermoplastic Elastomers KEY REQUIREMENTS WHY AVIENT?

ORTHOPEDIC PARTS MANUFACTURER O R T H O P E D I C S O L E I N S E R T • A super soft TPE (